Join Now - it is FREE

Basic level includes our interactive biotech chatroom, forum, biotech stock screener; you also receive the biotech digest in your email everyday.

AC Immune SA ($ACIU) stock perked up as the company announced the discovery of two new antibodies using its proprietary SupraAntigen platform. These antibodies will be used against two targets in the pathogenesis of neurodegenerative diseases. The first is Alpha-synuclein, an established target for Parkinson's disease and other Lewy body diseases and the second is TDP-43, a recently identified target of growing interest for neuro-orphan indications such as Frontotemporal Lobar Degeneration. AC Immune has already used its SupraAntigen platform for generating four products in clinical development, including crenezumab partnered with Genentech/Roche in Phase 3 for Alzheimer's.
The company stock gained over 7 percent in its previous trading session, trimming its 12 months losses to 46 percent.

Psychmedics Corp ($PMD) announced the launch of its new Synthetic Cannabinoids test – a hair test that looks for the compounds found in commonly-abused products such as K2, Spice and Blaze. The company plans to continually update to address changes in the Synthetic Cannabinoids market, adding additional compounds to the test. The procedure involves the use of a small sample of hair that is easily collected and shipped to Psychemedics' College of American Pathologists (CAP) and ISO/IEC 17025:2005 certified laboratory. The test can detect use over the previous few months.
The stock reacted positively to the news and gained over 3 percent in its previous trading session.

 

Cellectar Biosciences ($CLRB) announced that its Phospholipid Drug Conjugate (PDC) research program has generated "numerous" molecules that show significantly better pharmacologic activity compared to the payload molecule alone. The company said that the new molecules average more than a 20-fold increase in delivery of the PDC to cancerous cells.

InspireMD ($NSPR) received the notice from NYSE American that it no longer meets its listing requirements regarding minimum stockholders' equity and profitability. The notice will have no immediate effect on the company's listing.

Teligent ($TLGT) announced receiving the FDA approval for its Clobetasol Propionate Cream USP, 0.05%, Emollient. This is the fourth approval for the company this year. Teligent plans to launch the product in the fourth quarter this year.

Medtronic plc ($MDT) announced receiving CE Mark certification for its Attain Stability Quad MRI SureScan left heart lead, designed for precise lead placement and stability in cardiac resynchronization therapy (CRT) for heart failure.

 

Dr. Reddy’s Laboratories ($RDY) announced its new collaboration with Encore Dermatology. Under the terms of the deal, the company has out-licensed DFD-06, a high potency steroid for the potential treatment of plaque psoriasis. Encore will be responsible for commercialization in the U.S. Promiusof Dr. Reddy’s Laboratories will be eligible to receive up to $32.5 million in milestones and a fixed royalty on net sales.

CRISPR Therapeutics ($CRSP) reported its new two-year research collaboration with Massachusetts General Hospital Cancer Center to develop T cell therapies for cancer. The deal also has license option agreement attached to it. The companies did not disclose the financial terms of the deal.

Brokerage Action Company Rating Price Target Impact on Share Price
Leerink Swann Initiates CymaBay Therapeutics (CBAY)
Outperform $12.00 Low

Bank of America Corporation Upgrades IDEXX Laboratories (IDXX)
Neutral -> Buy N/A
Needham & Company LLC Initiates LivaNova PLC (LIVN)
Hold Low

William Blair Reiterates PTC Therapeutics (PTCT)
Market Perform N/A
SunTrust Banks Downgrades Ultragenyx Pharmaceutical (RARE)
Buy -> Hold $55.00 Low

Gainers (% price change)Last TradeChangeMkt CapRadNet Inc.RDNT9.88+1.27 (14.83%)466.76MZIOPHARM Oncology Inc.ZIOP5.44+0.40 (7.94%)772.28MInsmed IncorporatedINSM12.83+0.85 (7.10%)800.31MRockwell Medical IncRMTI6.65+0.34 (5.39%)342.98MImmunomedics, Inc.IMMU9.47+0.46 (5.11%)1.05BLosers (% price change)CARDIOME PHARMA CORPCRME2.11-0.49 (-18.85%)107.97MTenet Healthcare CorpTHC15.58-0.98 (-5.92%)1.57BBioScrip IncBIOS2.79-0.17 (-5.74%)355.66MFluidigm CorporationFLDM3.55-0.21 (-5.59%)104.42MBioDelivery Sciences IntlBDSI3.10-0.15 (-4.62%)171.98MMost Actives (dollar volume)Johnson & JohnsonJNJ134.70+1.25 (0.94%)361.53BPfizer Inc.PFE33.15+0.39 (1.19%)197.41BUnitedHealth Group IncUNH194.79+2.76 (1.44%)188.33BCelgene CorporationCELG130.29+2.86 (2.24%)101.93BShire PLC (ADR)SHPG143.16+2.31 (1.64%)42.92B